NAS:NXTC (N/A)

NextCure Inc

$ 19.09 1.54 (8.77%)
Volume: 34,318 Avg Vol (1m): 110,832
Market Cap $: 433.63 Mil Enterprise Value $: 298.92 Mil
P/E (TTM): 0.00 P/B: 0.00
Earnings Power Value 0
Net Current Asset Value -5.86
Tangible Book -4.68
Projected FCF 0
Median P/S Value 0
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 5.2/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 293.85
Cash-To-Debt range over the past 10 years
Min: 9.8, Med: 151.83, Max: 293.85
Current: 293.85
9.8
293.85
Debt-to-Equity -0.01
Debt-to-Equity range over the past 10 years
Min: -0.04, Med: -0.02, Max: -0.01
Current: -0.01
-0.04
-0.01
Debt-to-EBITDA -0.02
Debt-to-EBITDA range over the past 10 years
Min: -0.06, Med: -0.04, Max: -0.02
Current: -0.02
-0.06
-0.02

Profitability & Growth : 2/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
ROA % -27.29
ROA range over the past 10 years
Min: -79.46, Med: -53.38, Max: -27.29
Current: -27.29
-79.46
-27.29
ROC (Joel Greenblatt) % -216.50
ROC (Joel Greenblatt) range over the past 10 years
Min: -216.5, Med: -185.83, Max: -155.16
Current: -216.5
-216.5
-155.16

» NXTC's 30-Y Financials

Financials (Next Earnings Date: 2019-09-10)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:NXTC

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Biotechnology » Biotechnology    NAICS : 325412    SIC : 2834
Compare
Traded in other countries
Address

Ratios

Current vs industry vs history
EV-to-EBIT -12.86
EV-to-EBIT range over the past 10 years
Min: -12.92, Med: 0, Max: 0
Current: -12.86
-12.92
0
EV-to-EBITDA -13.91
EV-to-EBITDA range over the past 10 years
Min: -13.97, Med: 0, Max: 0
Current: -13.91
-13.97
0
Current Ratio 13.19
Current Ratio range over the past 10 years
Min: 3.02, Med: 8.11, Max: 13.19
Current: 13.19
3.02
13.19
Quick Ratio 13.19
Quick Ratio range over the past 10 years
Min: 3.02, Med: 8.11, Max: 13.19
Current: 13.19
3.02
13.19

Dividend & Buy Back

Current vs industry vs history

Valuation & Return

Current vs industry vs history
Earnings Yield (Joel Greenblatt) % -7.77
Earnings Yield (Greenblatt) range over the past 10 years
Min: -12.88, Med: 0, Max: 0
Current: -7.77
-12.88
0

More Statistics

Analyst Estimate

Piotroski F-Score Details